We are live on ! Find out more
JANX icon

Janux Therapeutics
JANX

64 hedge funds and large institutions have $360M invested in Janux Therapeutics in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 11 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more call options, than puts

Call options by funds: $60K | Put options by funds: $10K

145% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 11

100% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 7

12% more funds holding

Funds holding: 57 → 64 (+7)

2% more capital invested

Capital invested by funds: $354M → $360M (+$6.28M)

3.39% less ownership

Funds ownership: 76.1% → 72.71% (-3.4%)

Holders
64
Holders Change
+7
Holders Change %
+12.28%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
27
Reduced
11
Closed
7
Calls
$60K
Puts
$10K
Net Calls
+$50K
Net Calls Change
+$30K

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$1.78M
2
BlackRock
BlackRock
New York
+$1.06M
3
Morgan Stanley
Morgan Stanley
New York
+$990K
4
Cerity Partners
Cerity Partners
New York
+$527K
5
ZIM
Zacks Investment Management
Illinois
+$509K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$14.5M
2
Citadel Advisors
Citadel Advisors
Florida
-$2.69M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$1.18M
4
JP Morgan Chase
JP Morgan Chase
New York
-$1.13M
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$1.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$473K +$215K +24,867 +129%
Bank of America
27
Bank of America
North Carolina
$470K +$115K +13,261 +43%
Goldman Sachs
28
Goldman Sachs
New York
$429K +$220K +25,404 +175%
Swiss National Bank
29
Swiss National Bank
Switzerland
$341K +$77.8K +9,000 +39%
Allspring Global Investments
30
Allspring Global Investments
North Carolina
$282K +$217K +25,105 +2,166%
RhumbLine Advisers
31
RhumbLine Advisers
Massachusetts
$280K -$3.87K -447 -2%
Two Sigma Advisers
32
Two Sigma Advisers
New York
$253K +$204K +23,600 New
CS
33
Credit Suisse
Switzerland
$196K +$22.4K +2,595 +17%
JP Morgan Chase
34
JP Morgan Chase
New York
$190K -$1.13M -130,873 -88%
AllianceBernstein
35
AllianceBernstein
Tennessee
$186K +$4.41K +510 +3%
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$184K +$35.6K +4,119 +32%
State of Wisconsin Investment Board
37
State of Wisconsin Investment Board
Wisconsin
$162K +$40.3K +4,655 +44%
ETC
38
Exchange Traded Concepts
Oklahoma
$152K +$31.1K +3,602 +34%
Connor, Clark & Lunn Investment Management (CC&L)
39
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$138K +$111K +12,816 New
American Century Companies
40
American Century Companies
Missouri
$123K +$99K +11,443 New
MIM
41
MetLife Investment Management
New Jersey
$114K – – –
OWP
42
Old Well Partners
North Carolina
$111K – – –
Legal & General Group
43
Legal & General Group
United Kingdom
$106K – – –
SG Americas Securities
44
SG Americas Securities
New York
$100K +$80.8K +9,345 New
AIG
45
American International Group
New York
$92.2K -$303 -35 -0.4%
Deutsche Bank
46
Deutsche Bank
Germany
$74.8K – – –
CUAMC
47
China Universal Asset Management Company
China
$57.3K +$46.2K +5,343 New
Wells Fargo
48
Wells Fargo
California
$56.7K +$8.85K +1,023 +24%
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$54.2K -$303 -35 -0.7%
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$51K +$11.2K +1,300 +38%
1
2
3

JANX Hedge Fund Activity: Q4 2023 in Review

64 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Janux Therapeutics (JANX) for Q4 2023, worth a combined $360M — up 1.8% from $354M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new JANX positions and 7 closed out — a net gain of 7 holders — while 27 added to existing stakes and 11 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $1.78M. The largest seller was Fidelity Investments, cutting an estimated $14.5M.

  • 64 institutional investors held Janux Therapeutics (JANX) as of Q4 2023, up from 57 in Q3 2023.
  • Funds reported $360M of Janux Therapeutics stock for Q4 2023, up 1.8% quarter-over-quarter.
  • 14 funds opened new Janux Therapeutics positions in Q4 2023 and 7 closed out, a net change of +7 holders.
  • The largest Janux Therapeutics buyer in Q4 2023 was Adage Capital Partners, an estimated $1.78M added.
  • The largest Janux Therapeutics seller in Q4 2023 was Fidelity Investments, an estimated $14.5M sold.

Based on aggregated 13F filings for Q4 2023.